Ute Lander

Title: Ute Lander: Innovator in Pharmaceutical Compositions

Introduction

Ute Lander is a prominent inventor based in Dannenfels, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions. With a total of four patents to her name, Lander's work has the potential to impact the treatment of various health conditions.

Latest Patents

Lander's latest patents include innovative formulations aimed at treating Hepatitis C Virus (HCV). One notable patent features solid pharmaceutical compositions that comprise two key compounds. The first layer of this composition includes 100 mg of Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a surfactant, all formulated in an amorphous solid dispersion. The second layer contains 40 mg of Compound 2, also combined with a hydrophilic polymer and surfactant in a similar formulation. Another patent focuses on solid retard formulations based on solid dispersions, which include a melt-processed solid dispersion product containing an active agent and specific polymers.

Career Highlights

Throughout her career, Ute Lander has worked with notable companies in the pharmaceutical industry, including AbbVie Deutschland GmbH and AbbVie Inc. Her expertise in pharmaceutical formulations has positioned her as a valuable asset in the development of innovative treatments.

Collaborations

Lander has collaborated with esteemed colleagues such as Bernd Liepold and Jörg Rosenberg. These partnerships have contributed to her success and the advancement of her research in pharmaceutical compositions.

Conclusion

Ute Lander's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of various health conditions.